In an analysis from the phase II CALGB 40603 Alliance trial reported in the Journal of Clinical Oncology, Shepherd et al found that the addition of carboplatin or bevacizumab to neoadjuvant chemotherapy was not associated with improved long term outcomes in patients with stage II or III cialis 10mg Larger and node positive tumors associate with greater chances of early recurrence